Type
. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy. Acta leprologica. 1983;1(3):133-41.
Type
. [Lucio-Latapí leprosy and the Lucio phenomenon]. Acta leprologica. 1983;1(3):115-32.
Type
. Rifampin in the treatment of leprosy. Reviews of infectious diseases. 1983;5 Suppl 3:S606-13.
Type
. [Study of 10 families from the leprosy cluster in the health areas belonging to the Enrique Cabrera teaching hospital]. Revista cubana de medicina tropical. 1983;35(2):202-12.
Type
. [Effect of beta-1,3 glucan and other immunomodulators of microbial origin on experimental leprosy in mice]. Acta leprologica. 1983;1(2):93-100.
Type
. [Evaluation of the campaign against leprosy conducted by the Grandes Endémies du Cap-Vert sector in the Dakar urban area from 1975 to 1979]. Acta leprologica. 1983;1(2):63-92.
Type
. [Should treatment be discontinued in the case of a lepromatous leprosy patient who follows treatment very irregularly?]. Acta leprologica. 1983;1(2):105-8.
Type
. [Survival of Mycobacterium leprae in human skin biopsies]. Acta leprologica. 1983;1(2):101-3.
Type
. Clofazimine in lepra (ENL) reaction, one year clinical trial. Leprosy in India. 1983;55(2):265-77.
Type
. Pathology and pathogenesis of predilective sites of nerve damage in leprous neuritis. Nerves in the arm and the face. Neurosurgical review. 1983;6(3):139-52.